Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) EBIT: 2019-2024

Historic EBIT for Cellebrite DI (CLBT) over the last 6 years, with Dec 2024 value amounting to $56.9 million.

  • Cellebrite DI's EBIT fell 2.34% to $19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.4 million, marking a year-over-year increase of 9.30%. This contributed to the annual value of $56.9 million for FY2024, which is 71.21% up from last year.
  • Cellebrite DI's EBIT amounted to $56.9 million in FY2024, which was up 71.21% from $33.2 million recorded in FY2023.
  • Over the past 5 years, Cellebrite DI's EBIT peaked at $56.9 million during FY2024, and registered a low of $1.0 million during FY2022.
  • Moreover, its 3-year median value for EBIT was $33.2 million (2023), whereas its average is $30.4 million.
  • In the last 5 years, Cellebrite DI's EBIT slumped by 92.45% in 2022 and then skyrocketed by 3,083.62% in 2023.
  • Cellebrite DI's EBIT (Yearly) stood at $9.2 million in 2020, then spiked by 49.95% to $13.8 million in 2021, then plummeted by 92.45% to $1.0 million in 2022, then surged by 3,083.62% to $33.2 million in 2023, then surged by 71.21% to $56.9 million in 2024.